Risk factors for unsuccessful medical abortion with mifepristone and misoprostol

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 4, 2007, Pages 462-466

  Haimov Kochman, Ronit ^a   Arbel, Revital ^a   Sciaky Tamir, Yael ^a   Brzezinski, Amnon ^a   Laufer, Neri ^a   Yagel, Simcha ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

hCG; Abortion; Mifepristone; Risk factors; Ultrasound

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; MIFEGINE; MIFEPRISTONE; MISOPROSTOL; UNCLASSIFIED DRUG;

ABORTION; ADOLESCENT; ADULT; ALGORITHM; CONCEPTION; ECHOGRAPHY; ENDOMETRIUM; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MIFEPRISTONE; MISOPROSTOL; PARITY; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS;

EID: 34248572120     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701203632     Document Type: Review

References (19)

1. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13:2962-5.
2. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG. 2002;109:1281-9.
3. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241-7.
4. Rorbye C, Norgaard M, Vestermark V, Nilas L. Medical abortion. Defining success and categorizing failures. Contraception. 2003;68:247-51.
5. Kulier R, Gulmezoglu A, Hofmeyr G, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004;1:CD002855.
6. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med. 1998;7:360-6.
7. Rossi B, Creinin MD, Meyn LA. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception. 2004;70:313-7.
8. Paul M, Schaff E, Nichols M. The roles of clinical assessment, human chorionic gonadotrophin assays, and ultrasonography in medical abortion practice. Am J Obstet Gynecol. 2000;183(suppl):34-43.
9. Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotrophin levels and endometrial thickness after medical abortion. Contraception. 2001;63:255-6.
10. Cowett AA, Cohen LS, Lichtenberg ES, Stika CS. Ultrasound evaluation of the endometrium after medical termination of pregnancy. Obstet Gynecol. 2004;103:871-5.
11. Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J. NICHD Management of Early Pregnancy Failure Trial. Int J Gynaecol Obstet. 2004;86:22-6.
12. Luise C, Jermy K, Collons WP, Bourne TH. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol. 2002;19:580-2.
13. Fielding SL, Schaff EA, Nam NY. Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days. Contraception. 2002;66:27-31.
14. Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol. 2003;109:190-5.
15. Acharya G, Haugen M, Brathen A, Nilsen I, Maltau JM. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. Acta Obstet Gynecol Scand. 2004;83:390-4.
16. Rorbye C, Norgaard M, Nilas L. Prediction of late failure after medical abortion from serial beta-hCG measurements and ultrasonography. Hum Reprod. 2004;19:85-9.
17. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception. 2000;62:297-303.
18. Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol. 2004;103:738-45.
19. Honkanen H, Ranta S, Ylikorkala O, Heikinheimo O. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod. 2002;17:2315-9.